CURRICULUM VITAE
MICHAEL P. RIVEY
Address: 6015 Sunview Dr.Telephone: 406-251-3369(home)
Missoula, MT 59801 406-243-6796(work)
PROFESSIONAL GOALS
1.Involvement in development and execution of clinical pharmacy services.
2.Participation in design and implementation of educational services to provide current medical information concerning drug therapy.
3.Participation in the investigation and documentation of issues in health care relating to pharmacy.
EDUCATION
Master of Science in Pharmacy, Clinical and Hospital Pharmacy Division, University of Iowa, December 1982. Thesis committee: Mary J. Berg, Pharm.D., Boris A. Vern, M.D., Richard Leff, Pharm.D.
Courses: advanced therapeutics, biostatistics, clinical toxicology, epidemiology, advanced pharmacokinetics and biopharmaceutics, clinical pharmacokinetics, research methods, advanced neurology, antimicrobials, nuclear pharmacy, and thesis research.
Bachelor of Science in Pharmacy, University of Iowa, May 1974.
PROFESSIONAL EXPERIENCE
Professor, July 1998 to present.
* Chair of Pharmacy Practice: November 2003 to present
Associate Professor, July 1991 to 1998
Assistant Professor, July 1984 to 1991, School of Pharmacy, University of Montana, Missoula, Montana.
Dean: David Forbes, Ph.D.
1.Instructor for clinical pharmacy curriculum, including Therapeutics Sequence, and other practice-related courses.
a. Focus areas: internal medicine, anticoagulation, infectious disease
2.Residency Program Director for PGY1 residency in Pharmacy Practice
2.Direction of senior students during clinical clerkship and hospital externship at Community Medical Center, Missoula, Mt.
3.Instruction in courses for Psychology graduate students, Physical Therapy students, and Nurse Practitioner students.
4.Instruction of Pharm.D. students in distance-learning external Pharm.D. program.
Clinical Consultant and Residency Program Director, April 2004 to present. Community Medical Center, Missoula, Montana.
Consultant to clinical pharmacy services in 145-bed hospital. Manager of pharmacokinetics service. Residency Program Director for pharmacy practice residency jointly sponsored by CMC and UM, and primary preceptor for that program at CMC.
Michael P. Rivey, CVPage 2
PROFESSIONAL EXPERIENCE (continued):
Clinical Coordinator, December 1984 to April 2004, Community Medical Center, Missoula, Montana.
Coordinator for clinical pharmacy services in 145-bed community hospital. Responsible for clinical program development, drug utilization review including antibiotic review, pharmacokinetic service, drug therapy monitoring service and drug information. Residency Program Director since 2001. Member of P&T, Infection Control, Physician QI, and Diabetes Task Force Committees.
Assistant Clinical Instructor, February 1984 to May 1984, University of Iowa, Iowa City, Iowa.
Instructor of clinical pharmacy clerkship in adult medicine for senior pharmacy students at Veterans Administration Hospital. Maintained clinical practice in pulmonary medicine ward and assisted with clinical nutrition team.
Clinical Pharmacy Resident (ASHP approved), January 1983 to December 1983, Veterans Administration Medical Center, Iowa City, Iowa.
Preceptors: Michael R. Alexander, M.S. and Alan Mustion, B.S.
1.Pulmonary medicine, under supervision of Michael R. Alexander, M.S., 2 months service on medical ward team; responsibilities of team included medical intensive care unit.
2.Internal medicine, under supervision of Jerry W. Taylor, Pharm.D. and Michael R. Alexander, M.S., 4 months.
3.Psychiatric service, under supervision of Bruce Alexander, Pharm.D. 2 months.
4.Clinical pharmacokinetics service, under supervision of Randall A. Prince, Pharm.D., 2 months.
5.Administrative practice and projects, under supervision of Alan Mustion, B.S., 2 months.
6.Clinical pharmacist in outpatient pulmonary clinic, 12 months.
7.Participation in undergraduate and Pharm.D. student teaching, 9 months.
8.Development of technician training lecture course.
9.Assistance with clinical research projects.
10.Inspection of pharmacy services at Quincy Soldiers Home.
11.Presentations to medical staff and students during staffing rounds.
12.Participation with Total Parenteral Nutrition team.
Teaching Assistant, September 1980 to July 1982, Iowa Drug Information Service (IDIS), University of Iowa, Iowa City, Iowa.
Indexed medical literature into computer-based drug information system and handled drug information requests from subscribers.
Staff Pharmacist, July 1974 to August 1980. various settings and locations.
Provided services to wide spectrum of pharmacy operations including clinic, community, and hospital pharmacies.
Michael P. Rivey, CVPage 3
PROFESSIONAL EXPERIENCE (continued):
Pharmacy Manager, April 1977 to March 1978, Cal-Meds, Inc., Hayward, California.
Provided unit dose pharmacy services to skilled nursing facilities in San Francisco bay area; involvement in therapy consultation and review, and nursing inservice education. Preceptor
to clinical rotation for senior students from University of Pacific College of Pharmacy.
Pharmacy Intern and Staff, September 1974 to May 1975, Mohave General Hospital, Kingman, Arizona.
Provided inpatient and outpatient pharmacy services, comprehensive IV admixture program, and nursing inservice education. Member of CPR team and Pharmacy and Therapeutics Committee.
PUBLICATIONS
Tietje TM, Davis AB, Rivey MP. Comparison of two methods of local anesthetic-based injection as
partof a multimodal approach to pain management after total knee arthoplasty. J Pharm Practice 2014.Accepted for publication June 2014.
Aikens GB, Osmundson JR, Rivey MP. New oral pharmacotherapeutic agents for venous
thromboprophylaxis after total hip arthroplasty. World J Orthop2014; 5:188-203. Invited review. Published online July 2014.
Rivey MP, Allington DR. Gastrointestinal Infections with Enterotoxigenic Bacterium. Cases 146 &
147. ASHP’s PharmPrep 5th Edition, Ginsburg DB, editor, American Society of Health-
SystemPharmacists, Bethesda, MD. 2013. Accepted for publication.
Allington DR, Rivey MP. Multiple sclerosis (MS) in a primary care setting: Employing strategies
for improved patient outcomes. Invited continuing education (CE) program for ScientiaCME. Program included Powerpoint slide set with audio presentation, CE post-test questions, and recommendation for future program. Nov 2013.
Tietje TM, Allington DR, Rivey MP. Alemtuzumab: A place in therapy for multiple sclerosis.
Int JClin Med 2013;4:459-71. Published online October 2013
Allington DR, Davis A, Sutton J, Rivey MP. Multiple Sclerosis: Fundamental concepts and clinical
perspectives. Book chapter 22 for Advances in Viral Research II. iConcept Press LTD.
ISBN: 978-1477555-04-0.Sept 2013.
Aikens GB, Rivey MP, Hansen CJ. Primary venous thromboembolism prophylaxis in ambulatory
cancer patients. Ann Pharmacother 2013;47:198-209. Published online February 5, 2013.
doi 10.1345/aph.1R335
Nwankwo E, Allington DR, Rivey MP. Emerging oral immunomodulating agents- focus on
teriflunomide for the treatment of multiple sclerosis. Degenerative Neurological and Neuromuscular Disease 2012; 2:15-28.
Michael P. Rivey, CVPage 4
Publications (continued):
Summerday NM, Brown SJ, Allington D, Rivey MP. Vitamin D and Multiple Sclerosis: Review of a
possible association. J Pharm Practice 2012:25:75-84. e-publication in October 2011.
doi: 10.1177/0897190011421839
Rivey MP. Anticoagulation Therapy: A Point-of-Care Guide (book review). Ann Pharmacother
2011; 45:1034-5. Published online July 5, 2011. DOI 10.1345/aph.1Q188
Rivey MP. Pharmacotherapy Principles & Practice, 2nd edition (book review). Ann Pharmacother
2010; 44: 2042. Published online Nov 23, 2010. DOI10.1345/aph.1P485
Barten LJ, Allington DR, Procacci KA, Rivey MP. New approaches in the management of multiple
sclerosis. Drug Design, Development and Therapy 2010:4:1-23.
Rivey MP, Allington DR. Gastrointestinal Infections with Enterotoxigenic Bacterium. Cases 146 &
147. ASHP’s PharmPrep 4th Edition, Ginsburg DB, editor, American Society of Health
SystemPharmacists, Bethesda, MD. 2010. Published as online cases.
Barten LJ, Allington DR, Procacci KA, Rivey MP. Natalizumab update: a story of benefit and
risk. Drug Discovery Today: Therapeutic Strategies 2009. DOI 10.1016/j.ddstr.2009.10.002
Korenke AR, Rivey MP, Allington DR. Sustained-release fampridine for symptomatic treatment of
multiple sclerosis. Ann Pharmacother 2008;42:1458-65
Rivey MP, Allington DR. Gastrointestinal Infections. Cases 146 & 147. ASHP’s PharmPrep 3rd
Edition, Ginsburg DB, editor, American Society of Health SystemPharmacists, Bethesda,
MD. 2007.
Allington DR, Rivey MP. Gastrointestinal infections. Case 147. ASHP’s PharmPrep 3rd Edition,
Ginsburg DB, editor, American Society of Health SystemPharmacists, Bethesda, MD. 2007.
Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and
tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 2006;40:2037-42.
Colucci VJ and Rivey MP. Potential contribution of long-term rofecoxib in a patient with
cardiogenic syncope and ischemic stroke. J PharmTechnol 2006;22:174-8.
Keeley KA, Rivey MP, Allington DR. Natalizumab in the treatment of multiple sclerosis and
Crohn’s disease. Ann Pharmacother 2005;39:1833-43.
Rivey MP, Allington DR, Mathis JB. Evaluation of a risk assessment approach to venous
thromboembolism (VTE) prophylaxis in medically ill patients. Pharmacotherapy
2005;25:1502(abstract).
Michael P. Rivey, CVPage 5
Publications (continued):
Brophy DF, Dougherty JA, Garrelts JC, Parish RC, Rivey MP, Stumpf JL, Taylor CT, Mathis AS.
Venous thromboembolism prevention in acutely ill nonsurgical patients. AnnPharmacother
2005;39:1318-24.
Keeley KA, Mathis JB, Rivey MP. Medication Reconciliation in Hospitalized Patients. The New
Montana Pharmacist 2005; summer issue: pp 6-7. (nonrefereed)
Rivey MP, Allington DR. Gastrointestinal infections with enterotoxigenic bacterium.
Cases 146. pp 96-98. ASHP’s PharmPrep 2nd Edition, Ginsburg DB, editor, American Society of Health System Pharmacists, Bethesda, MD. 2004
Rivey MP, Allington DR. Gastrointestinal infections with enterotoxigenic bacterium.
Cases 147. CD medium. ASHP’s PharmPrep 2nd Edition, Ginsburg DB, editor, American Society of Health System Pharmacists, Bethesda, MD. 2004
Rivey MP, Beall HD, Woolley D, Brand P, Ganser A, James W. Investigation of intraarticular
bupivacaine in major orthopedic surgery for postoperative pain control. Pharmacotherapy
2001;21:366-7 (abstract).
Allington DR, Rivey MP. Quinupristin/dalforpristin: A therapeutic review. ClinTher 2001;23:
24-44.
Struckman DR, Rivey MP. Combined therapy with an angiotensin II receptor blocker and an
angiotensin-converting enzyme inhibitor in heart failure. Ann Pharmacother 2001;35:
242-8.
McHugh M, Allington DR, Rivey MP. Combination aspirin and dipyridamole & secondary stroke
prevetion. Montana Pharmacist 2000;24(No.3):6-7. (not refereed)
Carter JT, Allington DR, Rivey MP. Medical rehabilitation clerkship experience for Pharm.D.
students. Am J PharmEduc 2000;64:96S (abstract).
Colucci VJ, Rivey MP. Tolterodine-warfarin drug interaction. Ann Pharmacother 1999;33:1173-6.
Messer KG, Rivey MP. Feasibility study for pharmacist-directed asthma management in a pediatric practice. Pharmacotherapy 1999;19:521 (abstract).
Rivey MP, Allington DR, Henry Dunham AL. Necrotizing fasciitis associated with nonsteroidalantiinflammatory drug use. J PharmTechnol 1998;14:58-62.
Rivey MP. Pharmacist-managed drug therapy protocols at CommunityMedicalCenter. MSHP Newsletter 1997;6(No.3):3-5. (not refereed)
Stone JD, Rivey MP, Allington DR. Nitroprusside treatment of erythromelalgia in an adolescent female. Ann Pharmacother 1997;31:590-2.
Michael P. Rivey, CVPage 6
Publications (continued):
Rivey MP, Wood RD, Allington DR, Stratton TP, Erickson CC, Stenson TA. Pharmacy-managed protocol for warfarin use in orthopedic surgery patients. Am J Health-SystPharm 1995;52:1310-6.
Rivey MP, Allington DR, Stone JD, Serfoss ML. Alteration of carbamazepine pharmacokinetics in patients with traumatic brain injury. Brain Injury 1995;9:41-7.
Allington DR, Rivey MP. Multiple Sclerosis: An overview. American Pharmacy 1994, accepted for publication, but never published.
Rivey MP, Wood RD, Allington DR, Erickson CC. Evaluation of CoumadinR Protocol in Orthopedic Surgery Patients. Pharmacotherapy 1993;13:272 (abstract). Report in HospFormulary Oct 1993.
Rivey MP and Peterson JP. Pharmacy-managed, weight-based heparin protocol in a small hospital. Am J Hosp Pharm 1993;50:279-84. Report in Clinical Digest Series
Rivey MP, Allington DR, Stone JD. Evidence for alteration of carbamazepine pharmacokinetics during chronic therapy in patients with closed head injury. Pharmacotherapy 1992;12:505 (abstract). Report in CA/CTF.
Rivey MP, North GL, Harper DA, Cochran TG, Simmerman J. Evolution of a neonatal gentamicin dosing protocol in a small community hospital. J Perinatol 1992;12:346-53.
Rivey MP. Hepatitis: A viral alphabet. Montana Pharmacist 1992; 15(3):15-7 (not refereed)
Rivey MP and Stone JD. Carbamazepine hypersensitivity reaction. Brain Injury 1991;5:57-62.
Rivey MP and Peterson JP. Intradermal hepatitis B vaccination. DICP Ann Pharmacother 1991; 25:628-34.
Rivey MP. The School of Pharmacy self-study: What was it, and what did it say? Montana Pharmacist 1991;14:17-9. (not refereed)
Rivey MP. Psychotropic medication and falls in the elderly. Montana Pharmacist 1991;14:24-6. (not refereed)
Rivey MP, Morin LJ, Haakenson P. Attitudes of first-year pharmacystudents and preceptors to a "mini-externship" in hospital and community pharmacy practice. Am J PharmEduc 1990;54:146-9.
Rivey MP. Warfarin: New developments for an old drug. Montana Pharmacist 1990;13(1);11-4. (not refereed)
Michael P. Rivey, CVPage 7
Publications (continued):
Freeman D, Cochran G, Rivey M. Search for alterations in red blood cell enzymes in Alzheimer's Disease (abstract). ProcMontAcadSci 1989;49:165.
Rivey MP, Taylor JW, and Mullenix TA. TMP/SMX in renally-impaired patients with P. carinii pneumonia. Drug IntellClinPharm 1989;23:687-9.
Rivey MP. The use of technicians in pharmacy: A present perspective. Montana Pharmacist 1988;11:7-8,14. (not refereed)
Berg MJ, Ebert BE, Rivey NP, and Schottelius DD. Utilization of Km for phenytoin dosage after folate addition to patient regimen. Ther Drug Monitor 1987;9:304-305.
Rivey MP, Docktor WJ, and Winship MJ. Aminoglycoside monitoring in the neonate. Drug IntellClinPharm 1985;19:908-909.
Taylor JW, Murphy MJ, and Rivey MP. Clinical and electrophysiological evaluation of peripheral nerve function in chronic phenytoin therapy. Epilepsia 1985;26:416-420.
Rivey MP, Alexander MR, and Taylor JW. Dipyridamole: A critical evaluation. Drug IntellClin
Pharm 1984;18:869-880.
Taylor JW, Alexander B, Kathol RG, Alexander MR, Ebert B, and Rivey MP. Pharmacokinetic analysis of phenytoin-disulfiram interaction (abstract). Drug IntellClinPharm 1984;18:499.
Rivey MP, Schottelius DD, and Berg MJ. Phenytoin-folic acid: A review. Drug IntellClinPharm 1984;18:292-301.
Berg MJ, Rivey MP, Vern BA, Fischer LJ, and Schottelius DD. Phenytoin and folic acid: Individualized drug interaction. Ther Drug Monitor 1983;5:389-394.
Berg, MF, Fischer LJ, Rivey MP, Vern VA, and Schottelius DD. Phenytoin and folic acid interaction: A preliminary report. Ther Drug Monitor 1983;5:389-394.
Rivey MP. The Effect of Folic Acid Supplementation on Phenytoin Pharmacokinetics in Seizure Patients. Thesis, University of Iowa, December 1982.
POSTERS/PRESENTATIONS AT NATIONAL & STATE PROFESSIONAL MEETINGS
Rivey MP, Faul M, Chong C, Carter J. Vancomycin pharmacokinetics changes with prolonged
therapy. Poster presented to Northwest Pharmacy Convention, Coeur d’ alene, ID. May 2014
Michael P. Rivey, CVPage 8
Posters/Presentations at National & State Professional Meetings (continued):
Chong C, Rivey M, Allington D, Cady K. Quality assessment of inpatient managed anticoagulation
protocol. Poster presented to ASHP Midyear Clinical Meeting, Orlando, FL. December 2013.
Davis A, Tietje T, Roestenburg S, Rivey M, James W, Cady K. Comparison of intraoperative
injections for sustained analgesia after total knee arthroplasty. Poster presentation to
Northwest Pharmacy Convention, Coeur d’ alene, ID. May 2013
Davis A, Tietje T, Roestenburg S, Rivey M, James W, Cady K. Comparison of intraoperative
injections for sustained analgesia after total knee arthroplasty. Poster presentation to
ASHP Midyear Clinical Meeting, Las Vegas, NV. December 2012
Rivey MP, Carter JT, Docktor WJ, Allington DR. Incorporating pharmacy practice faculty
attributesinto a university-affiliated PGY1 residency. Poster presentation to L.S. Skaggs
Biomedical Research Symposium, Denver, CO. September 2012.
Summerday NM, Lyons D, Rivey MP, Cady K. Vancomycin dosing: A review of the efficacy of
pharmacist dosing protocol. Poster presentation to ASHP Midyear Clinical Meeting,
Anaheim, CA. December 2010.
Barten L, Rivey MP. Implementation of an asthma discharge protocol in a hospital emergency
department. Platform presentation to Western States Conference for Residents, Monterey,
CA. May 2010
Rivey MP. Osteoarthritis Rx Update. Presentation to Montana Gerontology Society Annual
Conference, Missoula, MT. April 2010
Byrd A, Rivey MP. Presciption drug abuse committee addresses concerns of deaths related to
prescription abuse. A review of stored unused medications and disposal. Platform
presentation to Western States Conference for Residents, Monterey, CA. May 2009
Korenke A, Rivey M, Hightower L, Cady K. Osteoporosis screening in a community medical
center. Platform presentation to Western States Conference for Residents, Monterey, CA.
May 2008
Johnson KM, Rivey MP, Mathis JB. ICU clinical pharmacy services in small hospitals: A
feasibility study. Platform presentation to Western States Conference for Residents, Monterey, CA. May 2007
Patrick B, Rivey M, Mathis JB. Lipid management in at risk patients. Platform presentation to
Western States Conference for Residents, Monterey, CA. May 2006
Patrick BN, Rivey MP, Allington DR, Mathis B. Lipid management in at-risk patients. Poster
presented to 40th ASHP Midyear Meeting. LasVegas. December 2005
Michael P. Rivey, CVPage 9
Posters/Presentations at National & State Professional Meetings (continued):
Rivey MP, Allington DR, Mathis JB. Evaluation of a risk assessment approach to venous
thromboembolism (VTE) prophylaxis in medically ill patients. Poster (refereed) presented
to ACCP Annual Meeting, San Francisco, CA. October 2005.
Rivey MP. Anticoagulation in the orthopaedic patient. Presentation to Second Annual Montana
Orthopaedic Conference, Missoula, MT. September 2005.
Rivey MP. NSAIDs Update. Presentation to Second Annual MontanaOrthopaedic Conference,
Missoula, MT. September 2005.
Rivey MP. Update on Prevention of Venous Thromboembolism. Presented to NorthValley
Hospital Grand Rounds, Whitefish, MT. February 2005. Sponsored by Aventis, Inc.
Rivey MP. Update on Prevention of Venous Thromboembolism. Presented to Community Medical
Center CE Education Series, Missoula, MT. January 2005. Sponsored by Aventis, Inc.
Keeley K, Rivey M, Allington D, Mathis B. Pharmacist-conducted medication histories. Poster
presented to ASHP Midyear Clinical Meeting, Orlando, Fl. December 2004.
Rivey MP. Update: Prevention and Treatment of Thrombosis. Presentation to Montana Pharmacy
Association (MPA) Fall Meeting, Whitefish, MT. October 2004. 2 hours.
Rivey MP and Gong WC. Training Residents in Self-Evaluation. Invited presentation to 2004
ASHP National Residency Preceptors Conference. Presented two 1.5 hr sessions. San Diego,
CA. August 2004
Hunt K and Rivey MP. Evaluation of venous thromboembolism (VTE) prophylaxis in surgical and
hospitalized patients. Poster (refereed) presented to ASHP Western States Residency
Conference, Monterey, CA, May 2004.
Rivey MP, Hunt KM, Allington DR. Evaluation of thrombosis risk assessment in surgical patients.
Poster (refereed) presented to 2nd ACCP-ESCP International Congress on Clinical
Pharmacy, Paris, France, April 29, 2004
Rivey MP, Allington DR, Reinivaara-Hall T, Mathis JB, Miller DC, McKernan JL. Development
of a Pharmacy Practice residency with a focus in pain management in a small hospital. Poster presented at American Society of Health-Systems Pharmacists (ASHP) Midyear Clinical Meeting, New Orleans, LA, December 2003.
Hunt K, Rivey MP. Evaluation of venous thromboembolism prophylaxis in surgical patients after
the implementation of a Thrombosis Risk Assessment sheet. Poster presented to ASHP Midyear Clinical Meeting, New Orleans, LA, December 2003.
Michael P. Rivey, CVPage 10
Posters/Presentations at National & State Professional Meetings (continued):
Carter JT, Allington DR, Rivey MP. Use of concept maps to assess clerkship students’ knowledge
of stroke. Poster presented at American Association of Colleges of Pharmacy (AACP) Annual Meeting, Minneapolis, MN, July 2003.
Carter JT, Miller SJ, Rivey MP. Student performance on negatively versus positively worded
multiple choice questions in a Therapeutics course. Poster presented at AACP Annual
Meeting, Kansas City, MO, July 2002.
Miller DC, Rivey MP, James W, et al. Effect of non-narcotic analgesics on post-operative use of
narcotics and antiemetics following major orthopedic surgery. Presented at ASHP Clinical
Midyear Meeting, New Orleans, LA, December 2001.
Rivey MP. New drug developments and new indications for existing drugs. Presentation to
Montana Pharmacy Association (MPA) Fall Meeting, Lewistown, MT, September 2001.
Cochran TG, Allington DR, CochranGA, Colucci VJ, Rivey MP, Williams AK. Student
assessment of program outcomes. Poster presented to AACP Annual Meeting, Toronto, Canada, July 2001.
Rivey MP, Beall HD, Woolley D, Brand P, Ganser A, James W. Investigation of intraarticular
bupivacaine in major orthopedic surgery for postoperative pain control. Poster presented
toAmericanCollege of Clinical Pharmacy Spring Practice and Research Forum, SaltLake
City, UT, April 2001.
Rivey MP. Moderator for Advances in Antithrombotic Therapy session at Montana Society of
Health-Systems Pharmacists (MSHP), West Yellowstone, MT, October 1999.
Messer KG, Rivey MP. Feasibility study for pharmacist-directed asthma management in a
pediatric practice. Poster presented at ACCP/ESCP International Congress on Clinical
Pharmacy, Orlando, FL, April 1999.
Christianson MA, Rivey MP. Evaluation of neonatal gentamicin protocol serum concentration monitoring revision. Poster presented at student research poster session at ASHP Clinical Midyear Meeting, New Orleans, LA, December 1996.
Rivey MP. Moderator for Management Case Studies session at ASHP Clinical Midyear Meeting, New Orleans, LA, December 1996.
Rivey MP. Asthma Care Update. Presented to MSHP Annual Meeting. Technician Session, Billing, Mt. September 1995.
Rivey MP. Patient Care Issues in the Management of Asthma: A Pharmacist's Focus. Presentation to MontanaState Pharmaceutical Assn. Annual Meeting, Helena, Mt. May 1995.
Michael P. Rivey, CVPage 11
Posters/Presentations at National & State Professional Meetings (continued):